Orodispersible donepezil

Easai and Pfizer have launched Aricept Evess, an orodispersible tablet containing 5mg or 10mg donepezil hydrochloride.

The orodispersible tablet should be placed on the tongue and given with or without water. Like Aricept film-coated tablets, Aricept Evess is indicated for the symptomatic treatment of mild to moderately severe Alzheimer's dementia. The orodispersible tablets are bioequivalent to the film-coated tablets; the dose recommendations for both formulations are the same.

Further information: Eisai-Pfizer 0208 6001400

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Gluten-free prescribing restricted to bread and mixes

Gluten-free prescribing restricted to bread and mixes

GPs in England are no longer able to prescribe gluten-free...

New vitamin D deficiency thresholds recommended

New vitamin D deficiency thresholds recommended

The National Osteoporosis Society (NOS) has updated...

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors may be linked to a doubling in the...

New MIMS table helps prescribers choose asthma inhalers

New MIMS table helps prescribers choose asthma inhalers

Prescribers can now turn to a handy MIMS comparison...